[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539923":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":30,"responsibleParty":46,"collaborators":50,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":18,"eligibilityCriteria":63,"healthyVolunteers":64,"sex":65,"minAge":66,"maxAge":18,"enrollmentInfo":67,"targetDuration":18,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":18,"overallStatus":33,"whyStopped":18,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"The University of Hong Kong","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Participating in Chronic Disease Co-Care Pilot Scheme","EXPERIMENTAL","Participants will receive comprehensive health management plans and necessary medication treatment from family doctors, based on their clinical condition. Nurse clinic will provide disease prevention education, health assessment, and counselling services, whereas allied health professionals (including optometrists, podiatrists, dietitians, and physiotherapists) will provide individualized intervention services for participants.",[13],"Combination Product: The Chronic Disease Co-Care (CDCC) Pilot Scheme",{"label":15,"type":16,"description":17,"interventionNames":18},"Not participating in Chronic Disease Co-Care Pilot Scheme","NO_INTERVENTION","Eligible non-CDCC participants will only be referred to the laboratories of a designated service provider by the research team for physical examination, blood tests, and urine test as a screening for DM and HT. No health management plans and necessary medication treatment would be provided to them in this study.",null,[20],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":18},"COMBINATION_PRODUCT","The Chronic Disease Co-Care (CDCC) Pilot Scheme",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Eric Yuk Fai Wan","CONTACT","852 2831 5057","yfwan@hku.hk",[31],{"facility":32,"status":33,"city":34,"state":18,"zip":18,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Jockey Club Building for Interdisciplinary Research 5 Sassoon Road, Pok Fu Lam, HONG KONG","RECRUITING","Hong Kong","HK",{"type":37,"coordinates":38},"Point",[39,40],114.17469,22.27832,{"lat":40,"lon":39},[43],{"name":26,"role":27,"phone":44,"phoneExt":45,"email":29},"852 28315057","852 28147475",{"type":47,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Dr. Eric Yuk Fai Wan","Assistant Professor",[51,54],{"name":52,"class":53},"Health and Medical Research Fund","OTHER_GOV",{"name":55,"class":56},"Primary Healthcare Office, Hong Kong","UNKNOWN","100539923","evaluation-of-the-chronic-disease-co-care-pilot-scheme-100539923",false,"NCT06310148","Evaluation of the Chronic Disease Co-Care Pilot Scheme","An Evaluation of the Effectiveness and Cost-effectiveness of the Chronic Disease Co-Care (CDCC) Pilot Scheme: a Commissioned Study","Inclusion Criteria of interventional group:\n\n* Hong Kong residents\n* Aged ≥45 years\n* Registered as a member of DHC\u002FDHC Express\n* Provided informed consent on sharing their data in the electronic Health Record Sharing System\n* Provided consent to join the CDCC Pilot Scheme Terms and Conditions.\n\nExclusion Criteria of interventional group:\n\n* With known history of DM or HT\n\nInclusion Criteria of comparison group:\n\n* Hong Kong residents\n* Aged ≥45 years\n* Provided informed consent for the study.\n\nExclusion Criteria of comparison group:\n\n* Without known history of DM or HT",true,"ALL","45 Years",{"count":68,"type":69},3772,"ESTIMATED","INTERVENTIONAL",[72],"NA","The Chronic Disease Co-Care (CDCC) Pilot Scheme is initiated for early screening and management of people with hypertension (HT), pre-diabetes mellitus (pre-DM) and diabetes mellitus (DM) in Hong Kong. This study will evaluate the quality of care, feasibility, acceptability, effectiveness and cost-effectiveness of the Scheme.\n\nThis is a 12-month cohort study among the District Health Centre (DHC) or DHC Express, healthcare providers, CDCC participants and a comparison group of 1,886 non-participants. All the person-in charge, 2 family doctors and 1 of each allied health provider from each DHC\u002FDHC Express will be administered with the questionnaires on quality of care and costing. All CDCC participants will be included in subject characteristics, among which a convenience sample of 548 will complete a telephone survey on experience, enablement and satisfaction of the CDCC Pilot Scheme. The health outcomes of 1,886 CDCC participants and 1,886 non-participants will be compared for evaluation of effectiveness and cost-effectiveness.\n\nParticipant characteristics, enablement, compliance to the standards of care, and costing of CDCC Pilot Scheme will be summarized using descriptive statistics. Differences in the proportion of patients meeting treatment targeted for HT, pre-DM and DM after 12 months will be compared by chi-squared test and logistic regressions. The incremental cost-effectiveness ratio will be evaluated by comparing with the World Health Organization (WHO) threshold. This study will inform future healthcare planning and policy for manpower and resource allocation.",[75,76,77,78,79],"Diabetes Mellitus, Type 2","Hypertension","Chronic Disease","Disease Management","Primary Healthcare","2024-03-20",{"date":82,"type":83},"2024-03-22","ACTUAL",{"date":85,"type":83},"2024-01-18",{"date":87,"type":69},"2026-12-31",{"name":5,"class":6},1]